Sponsor Quotes

Sponsor Quotes

 

The future of cancer therapeutics and cancer research is very promising. The diagnostics are becoming more sophisticated. Technologies, such as spatial transcriptomics, are helping us look at a tumor that may unveil new drug targets. AI is going to help us better understand how patient subsets are responding to treatment. Immunotherapy and precision medicine are becoming more innovative. However, if we are to continue this extraordinary progress we are making against cancer, as well as all of the other diseases affecting millions of Americans, it is going to require a commitment from our nation’s policy makers to provide robust annual budget increases for the lifesaving medical research that NIH funds.

Patricia M. LoRusso, DO, PhD (hc), FAACR
President, American Association for Cancer Research

“As the American Heart Association celebrates its centennial year, we can point to enormous progress in preventing and treating heart disease and stroke, in large part thanks to the National Institutes of Health (NIH). Robust NIH funding supports scientific research that inspires new areas of discovery, develops the next generation of scientists and improves patients’ health nationwide and around the world. We are pleased to stand with other public health and research organizations to urge Congress to increase federal funding for the NIH that will advance health and hope for everyone, everywhere.”

Cheryl Pegus, MD, MPH
Board of Directors
American Heart Association

 

“Thanks to the transformative research that is funded by NIH, there is real hope on the horizon for improving outcomes and even curing some forms of cancer and other devastating medical conditions. Innovative new treatments are emerging every day. NIH supports research that improves the health of our entire nation, creates jobs, boosts the economy and ensures that America remains a global leader in health innovation.”

John L. Cleveland, PhD
Center Director and Executive Vice President
Moffitt Cancer Center

“Federal funding for cancer research helps save lives and leads to an improved quality of life for patients and their loved ones. Thanks to a bipartisan commitment to supporting this research over the past several years, the cancer community has made monumental progress towards conquering cancer. However, robust and sustained federal research funding must continue to ensure that our vision of preventing and curing cancer comes to fruition, and every patient has equitable access to high-quality care. We call on Congress to maintain its investment in the National Institutes of Health and National Cancer Institute to ensure continued progress against cancer.”

Eric P. Winer, MD, FASCO
Chair of the Board
Association for Clinical Oncology

“Our nation’s investment in cancer research is at the heart of our ability to continue to accelerate progress against cancer. NCI has funded some of the most significant advances in cancer prevention, detection and treatment over the last 50 years resulting in a record 18 million cancer survivors in our nation today. In order to continue these advancements, we need Congress to continue to make sustained increased investments in research which is critical to advancing the cancer treatments and cures of the future.”

Karen E. Knudsen, MBA, PhD
American Cancer Society Cancer Action Network (ACS CAN)

“NIH’s investment in biomedical research has brought us critical cutting-edge treatments for people living with hematologic conditions. Continuity in research and funding will ensure enduring progress for sickle cell disease, blood cancers, and other serious blood disorders.”

Mohandas Narla, DSc
President, American Society of Hematology (ASH)

“The Association of American Cancer Institutes (AACI) represents over 100 leading academic cancer centers with a mutual goal of accelerating progress against cancer. Funding for the National Institutes of Health (NIH) and National Cancer Institute (NCI) drives that progress – and steady, predictable funding increases are critical to the future of cancer research. We are proud to partner with hundreds of organizations to highlight the urgent need to fund lifesaving discoveries at cancer centers and laboratories nationwide.”

Jennifer W. Pegher, MA, MBA
Executive Director, Association of American Cancer Institutes (AACI)

The historic federal investment in Alzheimer’s and dementia research funding over the last decade has fueled scientific progress in basic disease knowledge, risk reduction, early diagnosis, and treatment. Because of these advancements, multiple treatments which address the underlying biology of Alzheimer’s have been approved. With continued bipartisan support in Congress, scientists at the NIH will be empowered to continue this progress and one day achieve a world without Alzheimer’s and other dementia.

Rachel Conant
Senior Vice President, Public Policy, Alzheimer’s Association

“Every day across the country, anesthesiologists put NIH-funded scientific discoveries to use, making the care they deliver in operating rooms, intensive care units, and pain treatment clinics safer and more effective. Maintaining robust funding for the NIH is absolutely essential to ensuring that anesthesiologists have the knowledge and tools they need to advance health now and in the future. The Anesthesia Research Council, along with its sponsoring organizations—the American Society of Anesthesiologists, the International Anesthesia Research Society, and the Foundation for Anesthesia Education and Research—are proud to support the Rally for Medical Research and partner with other key stakeholders to advocate for NIH research.

Mark D. Neuman, MD, MSc,
Steering Committee Chair, Anesthesia Research Council

“As we support scientific discoveries that promote better health and wellness throughout our nation, elevated funding for the National Institute of Nursing Research is critical. We are grateful to our nurse scientists who are advancing these evidence-based interventions and leading translational research that addresses health equity, social determinants of health, population health, and health promotion.”

Deborah Trautman, PhD, RN, FAAN
President and Chief Executive Officer, American Association of Colleges of Nursing (AACN)

“NIH funding for human genetics and genomics research has been a catalyst for incredible innovation and breakthroughs in precision medicine. Congress’s bipartisan investment in NIH is paramount for advancing our understanding of the genetic causes of disease that affect children around the world. We need continued robust funding for NIH, which will empower researchers nationwide to unlock new discoveries, develop groundbreaking treatments and technologies, and enhance health outcomes for people everywhere.” 

Bruce D. Gelb, MD
President, American Society of Human Genetics (ASHG)

“I believe future historians will view the early 21st century as a pivotal time when humanity either made critical investments to eliminate cancer as a significant public health burden or failed to seize one of the greatest opportunities ever presented. The choice is ours.”

Roy A. Jensen, MD
Vice Chancellor and Director, The University of Kansas Cancer Center

“We are making progress in treating cancer, but that progress needs to benefit our populations more equitably. Some populations continue to face significant barriers to cancer screening, diagnosis and treatment. Sustained NIH support for cancer research — not just basic, translational, and clinical research, but also equity and community engagement initiatives — help us to reach rural and underserved populations. The UNM Comprehensive Cancer Center is grateful to Congress for its commitment to cancer research and health equity. That commitment helps us to bring the benefits of cancer research to all the people of New Mexico.”

Yolanda Sanchez, PhD
Director and Chief Executive Officer, The University of New Mexico Comprehensive Cancer Center

“Congress’ investment in medical research has enabled millions of Americans to overcome disease and live happy, healthy and more independent lives. The clinical advances made possible by this research are saving lives every day. Recent breakthroughs in cancer screening, immunotherapy, intravascular imaging and many other areas are radically transforming patient care. The National Institutes of Health, and the support of its efforts by members of Congress, as well as an army of relentless advocates, are responsible for this transformation, and I applaud their efforts.”

Robert A. Harrington, MD
Stephen and Suzanne Weiss Dean, Weill Cornell Medicine
Provost for Medical Affairs, Cornell University

“The National Institutes of Health is our premier biomedical institution which stands as a beacon of hope through its scientific and medical advancement. It funds the recruitment and training of the nation’s next generation of biomedical researchers. By investing in these bright minds, the U.S. can remain competitive globally and generate new medical miracles that bring hope to patients devastated by disease.” 

Beth A. Garvy, PhD
FASEB President

“Investing in the minds of our youth is not just a noble endeavor, but a crucial one. American Psychological Association Services champions the advancement of youth mental health research and applauds Congress’s recognition of the profound impact of supporting youth mental health research. Support from the National Institutes of Health for this critical research ensures we are not only fostering a healthier future for our children but also fortifying our society against the challenges of tomorrow. We must redouble our efforts to ensure that every young mind has the opportunity to thrive in a world that values mental health as a cornerstone of overall well-being.”

Mitch Prinstein, PhD, ABPP
Chief Science Officer, American Psychological Association (APA)

“Recognizing the connection between health and demography, the NIH has developed and sustained the field of population research. As a result, population scientists have made significant contributions in areas such as aging, adolescent health and development, and health disparities and advanced our understanding of the causes and consequences of population change. The Population Association of America and Association of Population Centers are proud to cosponsor the 2024 Rally for Medical Research and work with our colleagues to urge continued support for the NIH.”

Jennifer Glass, PhD
President, Population Association of America   

“The National Institutes of Health is a catalyst for American and global biomedical research. NIH acts as our internal research institute, but it also trains the next generation of biomedical researchers who will go forward to find a safe and effective therapeutic for every disease. With Congress’s help to invest in and to sustainably fund the NIH, the discoveries for cures can accelerate.”

Carol L. Beck, PharmD, PhD, President
American Society for Pharmacology and Experimental Therapeutics (ASPET)

“History has demonstrated that our nation’s health and economy benefit disproportionately from one of the safest bets in science: strong federal support for the NIH. Particularly as America’s population ages and new global pandemics threaten, it is imperative to provide robust funding for NIH to continue to build upon its proven track record of foundational science, clinical discoveries and workforce development.”

Barbara R. Snyder, President
Association of American Universities (AAU)

“The National Institutes of Health is the most important funder of physiology research, which seeks to understand the biological function of living organisms. These fundamental discoveries are essential for advancements in medical care, and strong, sustained funding for NIH is necessary to continue this important research and to support the next generation of physiologists.”

Dennis Brown, PhD, FAPS
Chief Science Officer, American Physiological Society